Does ENZALUTAMIDE Cause Transient ischaemic attack? 136 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Transient ischaemic attack have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.3% of all adverse event reports for ENZALUTAMIDE.
136
Reports of Transient ischaemic attack with ENZALUTAMIDE
0.3%
of all ENZALUTAMIDE reports
10
Deaths
87
Hospitalizations
How Dangerous Is Transient ischaemic attack From ENZALUTAMIDE?
Of the 136 reports, 10 (7.4%) resulted in death, 87 (64.0%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which ENZALUTAMIDE Alternatives Have Lower Transient ischaemic attack Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE